Patent · US Active

Integrated nucleic acid assays

US8772017B2 · kind B2 · utility

57Cited by
88References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 8, 2012
Grant dateJul 8, 2014
Priority date
Expiry dateJun 8, 2032

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB01L2400/0655
  • WIPO fieldChemical engineering
  • WIPO sectorChemistry

Abstract

Integrated microfluidic cartridges for nucleic acid extraction, amplification, and detection from clinical samples are disclosed. The devices are single-entry, sanitary, and disposable. The devices enable simplex or multiplex nucleic acid target detection, as for example: assay panels for multiple infectious agents, or assay panels for cancerous cell types. Methods for use of microfluidic cartridges in a fully automated, pneumatically controlled apparatus are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.